Harahap, A.S.; Subekti, I.; Panigoro, S.S.; Asmarinah; Lisnawati; Werdhani, R.A.; Agustina, H.; Khoirunnisa, D.; Mutmainnah, M.; Gultom, F.L.;
et al. Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression. Biomedicines 2023, 11, 2803.
https://doi.org/10.3390/biomedicines11102803
AMA Style
Harahap AS, Subekti I, Panigoro SS, Asmarinah, Lisnawati, Werdhani RA, Agustina H, Khoirunnisa D, Mutmainnah M, Gultom FL,
et al. Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression. Biomedicines. 2023; 11(10):2803.
https://doi.org/10.3390/biomedicines11102803
Chicago/Turabian Style
Harahap, Agnes Stephanie, Imam Subekti, Sonar Soni Panigoro, Asmarinah, Lisnawati, Retno Asti Werdhani, Hasrayati Agustina, Dina Khoirunnisa, Mutiah Mutmainnah, Fajar Lamhot Gultom,
and et al. 2023. "Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression" Biomedicines 11, no. 10: 2803.
https://doi.org/10.3390/biomedicines11102803
APA Style
Harahap, A. S., Subekti, I., Panigoro, S. S., Asmarinah, Lisnawati, Werdhani, R. A., Agustina, H., Khoirunnisa, D., Mutmainnah, M., Gultom, F. L., Assadyk, A. H., & Ham, M. F.
(2023). Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression. Biomedicines, 11(10), 2803.
https://doi.org/10.3390/biomedicines11102803
